ArticleNPJ science of food2026
In vitro gut microbial catabolism of ferulic acid is characterized by interindividual variability.
Article in NPJ science of food, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Intestinal Fate of Phenolic Substances in Honey: Metabolism by Gut Microbiota, Regulation of Bioavailability, and Its Prebiotic Effects on Host Health.Foods (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Interindividual variability in gut microbial metabolism of 4'-hydroxy-3'-methoxycinnamic acid (ferulic acid, FA), a major phenolic acid in cereals, may influence health outcomes and nutritional guidance; however, distinct metabotypes remain poorly defined. We investigated FA metabolism using in vitro fecal batch incubations from 18 individuals, combining ¹H NMR metabolomics with 16S rRNA amplicon sequencing. All individuals produced a shared set of FA-derived catabolites, but differed markedly in the rate and extent of FA conversion, enabling the identification of interindividual metabolic signatures. FA degradation was slower in older donors. Early 3-(3'-hydroxyphenyl)propanoic acid producers had lower tryptophan, and high 3-phenylpropanoic acid producers exhibited higher fumarate compared to higher 3-(3',4'-dihydroxyphenyl)propanoic acid producers. Late 3'-hydroxyphenylacetic acid producers had higher alpha diversity. Microbiota composition showed only weak associations with metabolic signatures, suggesting that functional variability rather than taxonomic differences drives interindividual differences in FA catabolism. These findings support the existence of functional FA metabolic signatures and highlight the need for in vivo studies to elucidate their physiological relevance.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.